Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Personal

Algernon Pharmaceuticals Receives Notice of Allowance from USPTO For Repirinast in Kidney Disease Patent

VANCOUVER, British Columbia, Jan. 06, 2025 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage pharmaceutical development company, is pleased to announce t

By: financialpost.com

Jan 06 2025
46
14776 Views

About NP-251 (Repirinast) Read More

Related

Kompleye Receives Reauthorization from The Cyber AB to Perform CMMC Assessments

Asante Announces Director Changes

Brompton Funds Announces ETF Name Change

Village Farms International and Hemp for Victory File Request for Reconsideration of Prior Motion to Disqualify DEA from Participation in Rescheduling Hearings

Singapore, Malaysia to Finalize Deal Creating Vast Economic Zone

STEP Energy Services Announces Normal Course Issuer Bid

Apollo, BC Partners Near Deal for $5.6 Billion GFL Environmental Services Unit

CI Financial Announces Receipt of Interim Court Order and Addition of Holdco Alternative to Plan of Arrangement with Mubadala Capital

NPCC Northeast Gas/Electric System Study

AGF Management Limited to Release Fiscal 2024 Financial Results on January 22, 2025

FAX Capital Files Early Warning Report Regarding Disposition of Common Shares of BioSyent Inc.

AGF Reports December 2024 Assets Under Management and Fee-Earning Assets

Facebook

Pinterest

Linkedin

Jan Jansen Easy Branches

Tumblr

Easy Branches

Instagram

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Next

Kompleye Receives Reauthorization from The Cyber AB to Perform CMMC Assessments